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Abstract
Background: Anatid herpesvirus 1 (AHV-1) is known for the difficulty of monitoring and controlling, because it has
a long period of asymptomatic carrier state in waterfowls. Furthermore, as a significant essential agent for viral
attachment, release, stability and virulence, gC (UL44) gene and its protein product (glycoprotein C) may play a key
role in the epidemiological screening. The objectives of this study were to rapidly, sensitively, quantitatively detect
gC gene of AHV-1 and provide the underlying basis for further investigating pcDNA3.1-gC DNA vaccine in infected
ducks by TaqMan™ fluorescent quantitative real-time PCR assay (FQ-PCR) with pcDNA3.1-gC plasmid.
Results: The repeatable and reproducible quantitative assay was established by the standard curve with a wide
dynamic range (eight logarithmic units of concentration) and very good correlation values (1.000). This protocol
was able to detect as little as 1.0 × 10
1 DNA copies per reaction and it was highly specific to AHV-1. The TaqMan™
FQ-PCR assay successfully detected the gC gene in tissue samples from pcDNA3.1-gC and AHV-1 attenuated
vaccine (AHV-1 Cha) strain inoculated ducks respectively.
Conclusions: The assay offers an attractive method for the detection of AHV-1, the investigation of distribution
pattern of AHV-1 in vivo and molecular epidemiological screening. Meanwhile, this method could expedite related
AHV-1 and gC DNA vaccine research.
Background
Anatid herpesvirus 1 (AHV-1) infection alternatively
known as duck virus enteritis (DVE), or duck plague
(DP), is one of the most widespread and devastating dis-
eases of waterfowls in the family Anatidae[1]. As an
acute and contagious herpesvirus, AHV-1 can infect
ducks, geese, and swans of all ages and species[2]. Since
the first outbreak in the Netherlands in 1923, AHV-1
had a dramatic impact on international trade of water-
fowls and waterfowl products throughout the world
[3-5]. Like other herpesviruses, AHV-1 can be carried
and periodically shed by recovered birds from the dis-
ease. Moreover, the reactivation of latent AHV-1 may
threaten domestic and migrating waterfowls populations
[6]. AHV-1 has already become an important potential
risk factor for waterfowls health.
As a significant agent of AHV-1, gC (UL44)g e n eh a s
seldom been reported about the research of its molecu-
lar biology, and its research level fall behind relatively in
other herpesviruses[7]. Although gC is nonessential
component for the viral replication, its protein product
(glycoprotein C) has several important biological func-
tions. As a multifunctional glycoprotein in Alphaherpes-
virinae, glycoprotein C involves in viral attachment,
release, stability, virulence and other functions [8-14].
Being situated on the envelope surface of mature virus
particles, glycoprotein C contains many antigen determi-
nants, and can adequately induce immune response
[15-18]. Some DNA vaccines based on gC gene from
other kinds of herpesviruses immunized in mice or
other relative animals could receive good immune
responses and protective efficacy [19-23], while the bio-
logical functions of AHV-1 glycoprotein C and DNA
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this study, pcDNA3.1-gC plasmid is not only used as
standard DNA to develop a standard curve for Taq-
Man™ FQ-PCR but also as a DNA vaccine to inoculate
ducks.
Many diagnosis and detection methods about AHV-1
have been reported in a long time, such as epidemiologi-
cal information, viral isolation and immunological meth-
ods [24-28]. These tests are laborious and time-
consuming resulting from requiring strict operation.
Thus, these methods can not be used to direct detec-
tion. In addition, the reliable diagnosis is difficult to
obtain from mixed or secondary infected waterfowls.
AHV-1 is difficult to be monitored and controlled
because it has a long period of asymptomatic carrier
state in waterfowls[29]. It is usually detected only during
the intermittent shedding period of the virus. Thus, how
to sensitively detect AHV-1 has become a significant
factor from infected waterfowls. PCR is a useful tool
with high sensitivity for detecting nucleic acids of virus
from the ducks [30-33]. However, the traditional PCR
assays still had some flaws, such as poor performance in
quantitation and a relative waste of time. It is not suita-
ble for large-scale applications.
In recent times, a more sensitive, time-saving and
advanced method has emerged in the field, which is
fluorescent quantitative real-time PCR (FQ-PCR). This
technology accurately quantifies target DNA in a given
sample and then could accurately detect viral loads in
clinical samples[34]. Yang and Guo have reported the
detection of AHV-1 with FQ-PCR method [35,36]. FQ-
PCR based on TaqMan™ technology provides certain
advantages including high sensitivity, high specificity,
and reproducibility, and has been widely used to quan-
tify the copies of viral genomic after optimization
[37-44]. In this study, the developed FQ-PCR method
was extremely valuable for AHV-1 detection. Moreover,
the results provide some interesting basic data that may
be beneficial to further investigate pcDNA3.1-gC DNA
vaccine in vivo in ducks.
Results
Development and optimization of a TaqMan™ FQ-PCR
Final concentrations of primers each of 0.5 μmol/L and
probe of 0.25 μmol/L were selected, and the optimized
annealing temperature was 53°C. The combination of
primers, probe and annealing temperature was used for
subsequent experiments.
Standard curve establishment
The amplification curves (Figure 1.a.) and standard
curve (Figure 1.b.) of the TaqMan™ FQ-PCR were gener-
ated by using the 10-fold dilutions of pcDNA3.1-gC,
which has already known its copies to undertake FQ-
PCR reaction under optimum conditions with the iCy-
cler IQ Detection System. The curve covered a dynamic
range of eight log units of concentration and displayed a
clear linear relationship with a correlation coefficient of
1.000 and high amplification efficiency (100%). By using
the following formula, we were able to quantify the
amount of unknown samples: Y = -3.321X + 45.822
(Y = threshold cycle, X = log starting quantity).
Amplification sensitivity, specificity, repeatability and
reproducibility
Ten-fold dilution series of pcDNA3.1-gC standard DNA
(from 1.0 × 10
5 to 1.0 × 10
0 copies/reaction) were tested
by the established FQ-PCR assay to evaluate the sensitiv-
ity of the system, the mean threshold cycle (Ct) values
were 29.60, 33.10, 36.43, 39.30, 42.57 and N/A respec-
tively. The results showed that the assay could detect
down to 1.0 × 10
1 copies per reaction (Figure 2.). All
liver samples were retested positive for AHV-1 from
infected ducks with the established FQ-PCR assay, it
indicated that this method was sensitive for clinical cases.
Comparisons were made between the established FQ-
PCR method and conventional PCR method by using 10-
fold dilutions of viral DNA from infected allantoic fluid
to calculate the end-point sensitivity of each assay. The
results showed that the established FQ-PCR could detect
viral DNA down to dilutions of 2.730 × 10
1,w h i l et h e
dilutions of only 2.730 × 10
4 for conventional PCR.
The specificity test showed that pcDNA3.1-gC, AHV-1
attenuated vaccine (AHV-1 Cha) strain virus and AHV-
1 virulent (AHV-1 Chv) strain virus were found positive
for AHV-1 by the established FQ-PCR assay, while the
bacteria, remaining viruses including negative control
(liver sample of the healthy duck) were negative (Figure
3). The results were confirmed by gel electrophoresis,
there was a band of the expected size (78 bp) observed
exclusively from samples of pcDNA3.1-gC, AHV-1 Cha
and AHV-1 Chv. It indicated that the established FQ-
PCR assay was highly specific.
In the intra-assay and inter-assay, the mean Ct values
and standard deviations (SD) values were calculated. As
shown in Table 1, the coefficient of variation (CV)
values ranged from 0.44% to 2.03%, indicating that this
assay was highly repeatable and reproducible.
Detection of AHV-1 gC gene in samples for practical
applications
AHV-1 gC gene and viral load quantification demon-
strated that the AHV-1 gC copies of each sample could
be calculated by using the Ct value determined from the
standard curve. As shown in Table 2, AHV-1 gC can be
detected in all analyzed tissues at 1 hour postinocula-
tion. gC copies of all tissues reached a peak at 1 hour
postinoculation in gC DNA vaccine-inoculated ducks,
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reached a peak at 4 hours postinoculation in AHV-1
Cha strain-infected ducks. The concentration of nucleic
acid in DNA vaccine-inoculated ducks maintained 10
7
copies/g level at 4 weeks postinoculation. The copies of
the liver, spleen and thymus were more than other tis-
sues in gC DNA vaccine-inoculated ducks, while the
copies of the duodenum and rectum were relatively low
in AHV-1 Cha strain-infected ducks.
Discussion
The accurate and prompt diagnosis of AHV-1 infection
in waterfowls is a vital part of surveillance and disease
control strategy. Currently, the diagnosis of AHV-1
usually depends on epidemiological information, clinical
symptoms, pathological changes and serological meth-
ods [45-47]. However, these methods are time-consum-
ing, inconvenient, and requiring special collection and
transport conditions to maintain the viability of the
virus, and the whole process may take 1 to 2 weeks.
Virus can not be promptly detected from infected water-
fowls with these methods. The conventional qualitative
PCR method is also developed for the diagnosis of
AHV-1 infection, which may not provide the sensitivity
that is needed to detect low-level of viral loads. FQ-PCR
is based on the conventional principles of PCR and has
b e i n gb e c o m ea ni n c r e a s i n g l yp o p u l a rw a yf o rt h ed i a g -
nosis of bacteria and viruses infection. The diagnostic
process requires only 4 hours for detection and quanti-
tation of bacteria and viruses from nucleic acid extrac-
tion to FQ-PCR.
The FQ-PCR assay has more advantages than conven-
tional qualitative PCR assays, including rapidity, higher
sensitivity, higher specificity, quantitive measurement,
decreased risk of cross-contamination through absence
of post-PCR handling and automated product detection
[48]. An oligonucleotide probe of the TaqMan™ FQ-PCR
assay is not included in conventional qualitative PCR,
Figure 1 The amplification curves (Figure 1.a.) and standard curve (Figure 1.b.) of the TaqMan™ FQ-PCR detection. Ten-fold dilutions of
standard DNA ranging from 1.0 × 10
8 to 1.0 × 10
1 copies/reaction were used (1-8), as indicated in the x-axis, whereas the corresponding Ct
values are presented on the y-axis. The correlation coefficient and the slope value of the regression curve were calculated and indicated.
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Page 3 of 10Figure 2 The sensitivity of TaqMan™ FQ-PCR detection. Ten-fold serial dilutions of AHV-1 standard template were used (1-6), 1.0 × 10
5-1.0 ×
10
0 copies/reaction of AHV-1 standard template. As shown in the figure, the detection limit for the assay was 1.0 × 10
1 copies.
Figure 3 The specificity of TaqMan™ FQ-PCR detection. The pcDNA3.1-gC (1), AHV-1 Cha (2), AHV-1 Chv (3), gosling new type viral enteritis
virus (4), duck hepatitis virus type1 (5), duck adenovirus (6), goose parvovirus (7), Marek’s disease virus (8), Pasteurella multocida (5:A) (9),
Escherichia coli (O78) (10), Salmonella enteritidis (No. 50338) (11), the liver DNA of the healthy duck (12) and NTC (13) were tested to evaluate the
specificity of the assay by FQ-PCR.
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labelled at 3’ with TAMRA as quencher. It facilitates
highly specific binding to the targeted sequence, and
results in greater accuracy in the measurement.
Previous studies have detected AHV-1 by FQ-PCR in
infected ducks [35,36]. However, Yang et al. developed a
relatively narrowed dynamic range for FQ-PCR, it may
not be beneficial to large-scale detection in various
infected cases. Guo et al. established a similar dynamic
range (from 1.0 × 10
9 to 1.0 × 10
2 copies), but the end-
point sensitivity (1.0 × 10
1 copies) was not included in
the standard curve, the method may not be reliable to
quantitate a low viral load (<1.0 × 10
2 copies). In this
study, the comparisons were carried out between the
established FQ-PCR method and conventional PCR
method for AHV-1 detection from infected allantoic
fluid, the results indicated that the established FQ-PCR
method is approximately 10
3 times more sensitive and
reliable than the conventional PCR method for clinical
cases. A FQ-PCR assay was established to be highly spe-
cific for AHV-1, and had a sensitive detection limit of
1.0 × 10
1 DNA copies per reaction in this study, which
produced excellent linear with the DNA concentration
from 1.0 × 10
8 to 1.0 × 10
1 copies, with correlation
coefficient of 1.000 and a reaction efficiency of 100%.
The linear amplification of this assay covered a wide
dynamic range suitable for quantitative applications.
The potential contamination of AHV-1 DNA that
could lead to false-positive results and it was a major
concern in this study. This problem was successfully
avoided through the findings of high Ct values (low
copies) in this assay. Furthermore, no template controls
(NTCs) always be included on every plate in every
experiment, which can identify the extent of pollution
during the test [49]. NTCs and template controls from
healthy ducks had no amplification signal in this assay,
it is reasonable to think that the sample amplification is
real.
The distribution and concentration of AHV-1 has
been investigated in AHV-1 Cha strain-infected ducks
by Qi [50]. This assay was similar with Qi’s report about
the distribution of the different kinds of tissues. AHV-1
attenuated vaccine can be distributed in various tissues
and organs of ducks within 1 hour by subcutaneous
route in this study, furthermore, the concentration of
nucleic acid maintained at least 10
6 copies/g level at 4
weeks postinoculation. They revealed that AHV-1 atte-
nuated vaccine can play an important role against the
virulent AHV-1 in the immune ducks, but the copies of
the duodenum and rectum were relatively low in
infected ducks, it implyed that the various inoculate
routes have large impact on the replication of vaccine
virus in digestive tracts, and consistents with the gradual
circulation of lymphocytes [6].
Plasmid DNA has been confirmed to widely distribu-
ted in the thymus, heart, lung, kidney, liver, mesenteric
lymph nodes and other organs in a short time by intra-
muscular injection of DNA vaccine [51,52]. In this
study, AHV-1 gC can be detected in all analyzed tissues
at 1 hour postinoculation, and the concentration of gC
maintained 10
7 copies/g level at 4 weeks postinocula-
tion. The copies of gC in the liver, spleen and thymus
were more than other tissues, and it may be due to plas-
mid was widely distributed in all tissues through the
lymphatic flow and blood circulation in a short time
[53]. These basic data can set the stage for further
research about gC DNA vaccine.
Currently, the surveillance of AHV-1 becomes difficult
because of the inability to differentiate the infected from
vaccinated animals (DIVA). The DIVA strategy has only
been recently put into practice for avian influenza virus
(AIV) [54,55]. In this study, the virus loads and gC gene
copy number can be accurately detected by the estab-
lished FQ-PCR from inoculated ducks, because the ani-
mals were certificated as AHV-1-free by qualitative PCR
assay before being infected with AHV-1 Cha and
pcDNA3.1-gC. Among the different DIVA strategies,
one approach is to use a DNA vaccine based on an
incomplete gC gene against AHV-1. If this vaccine will
be successfully constructed in the future, the developed
TaqMan™ FQ-PCR assay will become perfect for the
surveillance of AHV-1.
Table 1 Intra-assay and inter-assay of the TaqMan™ FQ-
PCR assay
Variation Copies of standard Crossing point
Mean SD
a CV (%)
b
Intra-assay 1.00E+08 19.73 0.15 0.77
1.00E+07 23.10 0.20 0.87
1.00E+06 26.37 0.29 1.09
1.00E+05 29.63 0.21 0.70
1.00E+04 33.07 0.31 0.92
1.00E+03 36.33 0.31 0.84
1.00E+02 39.50 0.17 0.44
1.00E+01 42.67 0.32 0.75
Inter-assay 1.00E+08 19.70 0.28 1.41
1.00E+07 23.09 0.47 2.03
1.00E+06 26.31 0.32 1.23
1.00E+05 29.59 0.42 1.42
1.00E+04 33.04 0.34 1.03
1.00E+03 36.35 0.41 1.14
1.00E+02 39.52 0.43 1.10
1.00E+01 42.70 0.41 0.97
Repeatability and reproducibility (R & R) of the TaqMan™ FQ-PCR assay.
a Standard deviation.
b Coefficient of variation.
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Page 6 of 10Conclusions
In summary, the established TaqMan™ FQ-PCR was a
rapid, highly specific, sensitive, repeatable and reprodu-
cible assay than conventional PCR method, and it was
extremely valuable for AHV-1 detection and quantita-
tion on the purpose of the disease transmission studies,
diagnostic assays and efficacy evaluation of drugs. Also
it provided some significant basic data that may be ben-
eficial to further investigate pcDNA3.1-gC DNA vaccine.
We are currently studying the dynamic distribution of
gC in AHV-1-infected and DNA vaccine-inoculated
ducks by using this method. We believe that this
approach could expedite related AHV-1 and gC DNA
vaccine research.
Methods
Viruses and bacteria
AHV-1 Cha strain and Escherichia coli JM109 were
obtained from Key Laboratory of Animal Diseases and
Human Health of Sichuan Province. According to the
gene libraries of AHV-1 constructed by the Avian Dis-
ease Research Center of Sichuan Agricultural University
[56], the pMD18-gC plasmid was obtained through a
1296 bp fragment (gC gene) of PCR amplification was
cloned into the pMD18-T vector (Takara, Japan), and
then the result of sequencing compared with the
sequences of AHV-1 in GenBank. Sequence was sub-
mitted to GenBank [GenBank: EU076811] by the Avian
Disease Research Center of Sichuan Agricultural Univer-
sity [57].
Gosling new type viral enteritis virus, duck hepatitis
virus type1, duck adenovirus, goose parvovirus, Marek’s
disease virus, AHV-1 Chv strain virus, Pasteurella mul-
tocida (5: A), Escherichia coli (O78) and Salmonella
enteritidis (No. 50338) were provided by Key Laboratory
of Animal Diseases and Human Health of Sichuan Pro-
vince. They were propagated and the nucleic acid was
extracted [58-60].
Standard templates preparation
The purified gC gene was obtained from pMD18-gC by
using restriction enzymes (EcoRIa n dXho I) (Takara,
Japan), and was inserted into the eukaryotic expression
vector pcDNA3.1(+) (Invitrogen, USA) according to the
manufacturer’s protocol. The constructed pcDNA3.1-gC
plasmid was transformed into Escherichia coli JM109
cells. pcDNA3.1-gC plasmid was extracted by TIANprep
plasmid extraction kit (Tiangen, China) according to
manufacturer’s protocol. The presence of target DNA
was confirmed by PCR amplification with primers P1
and P2 (generated by Takara, Japan) targeting the gC
gene on a Mycycler™ thermo cycler system (Bio-Rad,
USA), their sequences were listed in Table 3. The pro-
duct size was 1296 bp. DNA sequencing showed that
pcDNA3.1-gC is real.
PCR primers and probe design
The FQ-PCR assay primers and TaqMan™ probe (named
P3, P4 and P respectively, generated by Genecore Cor-
poration, China) design was carried out by using the
Primer Express™ software supplied by Applied Biosys-
tems according to the sequence of gC gene [GenBank:
EU076811] and their sequences were listed in Table 3.
The forward and reverse primers amplified a 78 bp frag-
ment of AHV-1 gC gene. The fluorogenic probe was
labelled at 5’ with FAM (6-carboxyfluorescein) dye as
reporter and labelled at 3’ with TAMRA (tetra-methyl-
carboxyrhodamine) as quencher.
Protocol optimization
FQ-PCR was performed in an iCycler iQ Multicolor
Real-Time PCR Detection System (Bio-Rad, USA) with a
reaction mixture (20 μL) containing 10 μL2×P r e m i x
Ex Taq™ (Takara, Japan) and 2 μL standard template
according to the manufacturer’s protocol. Autoclaved
double-filtered nanopure water was added to get the
final volume to 20 μL. The reactions were optimized in
triplicate based on primers (P3 and P4) and TaqMan™
probe (P) concentration selection criteria, which was
performed according to 5 × 5 matrix of primers concen-
trations (0.2, 0.3, 0.4, 0.5 and 0.6 μmol/L) and probe
concentrations (0.1, 0.2, 0.25, 0.3 and 0.35 μmol/L). The
two-step PCR cycling condition as follows: initial dena-
turation and hot-start Taq DNA polymerase activation
at 95°C for 5 min, 45 cycles of denaturation at 94°C for
5 s, primer annealing and extension at 53°C for 30 s
Table 3 Oligonucleotide sequences of primers and probe used in AHV-1 FQ-PCR detection
Name Type Sequences (5’ to 3’) Length
(nt)
Amplicon size
(bp)
P1 Forward CGGAATTCCAAAACGCCGCACAGATGAC 28 1296
P2 Reverse CCCTCGAGGTATTCAAATAATATTGTCTGC 30
P3 Forward GAAGGACGGAATGGTGGAAG 20 78
P4 Reverse AGCGGGTAACGAGATCTAATATTGA 25
P Probe FAM-CCAATGCATCGATCATCCCGGAA-TAMRA 23
The underlined sequences of P1 and P2 are EcoR I and Xho I restriction sites respectively
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extension stage. The tests were carried out by using the
0.2 mL PCR tubes (Axygen, USA).
standard curve establishment
The recombinant plasmid pcDNA3.1-gC was used to
establish standard curve as standard DNA of FQ-PCR.
pcDNA3.1-gC concentration was determined by taking
the absorbance at 260 nm by using a Smartspec 3000
spectrophotometer (Bio-Rad, USA) and purity was con-
firmed by using the 260/280 nm ratio. The pcDNA3.1-
gC copies/μL was calculated and the purified plasmid
DNA was serially diluted 10-fold in TE buffer, pH 8.0,
from 5.0 × 10
7 to 5.0 × 10
0 plasmid copies/μL. The Pri-
mers (P3 and P4) were used for this amplification,
These dilutions were used as amplification standards to
construct the standard curve by plotting the plasmid
copy number logarithm against the Ct values under
optimum conditions. The standard curve and its correla-
tion coefficient were generated through the software of
iCycler IQ Detection System (Bio-Rad, USA) according
to the manufacturer’s protocol.
Amplification sensitivity, specificity, repeatability and
reproducibility
The sensitivity of the assay was used as the limit extent of
detection when testing 10-fold diluted DNA standards in
triplicate. The dilution of plasmid pcDNA3.1-gC was ran-
ging from 1.0 × 10
5 to 1.0 × 10
0 copies/reaction. This test
was performed under optimum conditions.
The different 40 liver samples had been confirmed
positive for AHV-1 by using the conventional PCR from
infected ducks, these samples were retested with the
established FQ-PCR method to evaluate the sensitivity
of this method for clinical cases.
AHV-1 Cha strains was propagated in the allantoic
cavity of 10-day-old SPF duck embryo. The allantoic
fluid was harvested from dead embryo. Viral DNA from
allantoic fluid was extracted by using TIANamp viral
Genomic (DNA/RNA) extracting kit (Tiangen, China)
according to the manufacture’s instructions, then exam-
ined by the established FQ-PCR method and conven-
tional PCR under same circumstance in triplicate after it
was 10-fold diluted with sterile ultrapure water. The
detection limit of the FQ-PCR was determined based on
the highest dilution that resulted in the presence of Ct
value in real-time PCR detection. The detection limit of
the conventional PCR was determined through the high-
est dilution that resulted in the presence of clear ampli-
fied fragments (78 bp) on the agarose gel. The end-
point sensitivity of both assays were calculated.
The specificity of the assay was evaluated by testing
the different kinds of templates including pcDNA3.1-gC,
AHV-1 Cha, AHV-1 Chv, gosling new type viral
enteritis virus, duck hepatitis virus type1, duck adeno-
virus, goose parvovirus, Marek’s disease virus, Pasteur-
ella multocida (5: A), Escherichia coli (O78) and
Salmonella enteritidis (No. 50338), then the liver DNA
of the healthy duck should be added in this experiment
as a negative control.
In order to assess intra-assay variability, eight dilutions
of pcDNA3.1-gC (1.0 × 10
8-1.0 × 10
1 copies/reaction)
were prepared separately. These samples were assayed
simultaneously in triplicate in a same experiment. Five
experiments were performed on different days in order
to assess inter-assay variability, using eight pcDNA3.1-
gC dilutions (1.0 × 10
8-1.0 × 10
1 copies/reaction). All
tests were performed under optimum conditions. The
mean Ct values, SD values and CV values were calcu-
lated independently for each DNA dilution.
Detection of AHV-1 gC gene in samples for practical
applications
This study was conducted with 90 AHV-1-free Peking
ducks (28 days old) from a AHV-1-free farm which
were certificated with qualitative PCR as described by
Song[61]. 60 ducks were randomly divided into two
equal groups in this study (30 in each group). Thirty
non-immunized ducks in Groups 3 used as controls.
Ducks in Groups 1-2 were inoculated with 200 μg
pcDNA3.1-gC (2.714 × 10
13 copies) as DNA vaccine by
intramuscular route and with 0.2 mL AHV-1 Cha strain
vaccine (6.692 × 10
11 copies) by subcutaneous route
respectively. At each of ten sampling times, three vacci-
nated ducks of each immune group were chosen ran-
domly for sampling. The liver, pancreas, spleen, kidney,
lung, thymus, heart, brain, duodenum, rectum, Harder-
ian gland and bursa of Fabricius were collected at 1 h,
4 h, 8 h, 12 h, 1 d, 3 d, 5 d, 7 d, 2 wk and 4 wk postino-
culation respectively. DNA of all these samples were
extracted by Animal cell/tissue DNA magnetic bead
extraction kit (Bioeasy Technology, China) in Thermo
Scientific KingFisher (mL) (Thermo, USA) from 15 mg
tissues according to the manufacturer’s protocol, fol-
lowed by being dissolved in 50 μL sterile ultrapure
water. Then, 2 μL DNA of each sample was prepared to
detect AHV-1 gC accumulation in triplicate by Taq-
Man™ FQ-PCR.
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